TALS Annual CFO
-$60.86 M
-$20.87 M-52.19%
31 December 2022
Summary:
As of February 5, 2025, TALS annual cash flow from operations is -$60.86 million, with the most recent change of -$20.87 million (-52.19%) on December 31, 2022. During the last 3 years, it has fallen by -$43.20 million (-244.60%).TALS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TALS Quarterly CFO
-$14.68 M
+$2.22 M+13.15%
30 June 2023
Summary:
As of February 5, 2025, TALS quarterly cash flow from operations is -$14.68 million, with the most recent change of +$2.22 million (+13.15%) on June 30, 2023. Over the past year, it has increased by +$2.60 million (+15.05%).TALS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TALS TTM CFO
-$58.88 M
+$2.60 M+4.23%
30 June 2023
Summary:
As of February 5, 2025, TALS TTM cash flow from operations is -$58.88 million, with the most recent change of +$2.60 million (+4.23%) on June 30, 2023. Over the past year, it has dropped by -$5.36 million (-10.01%).TALS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TALS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.2% | +15.1% | -10.0% |
| 3 y3 years | -244.6% | -320.2% | -574.0% |
| 5 y5 years | -244.6% | -180.0% | -1023.0% |
TALS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +244.6% | +320.2% | +1023.0% |
Talaris Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$14.68 M(-13.2%) | -$58.88 M(-4.2%) |
| Mar 2023 | - | -$16.90 M(+21.9%) | -$61.48 M(+1.0%) |
| Dec 2022 | -$60.86 M(+52.2%) | -$13.87 M(+3.3%) | -$60.86 M(+7.1%) |
| Sept 2022 | - | -$13.43 M(-22.3%) | -$56.82 M(+6.2%) |
| June 2022 | - | -$17.28 M(+6.1%) | -$53.52 M(+13.3%) |
| Mar 2022 | - | -$16.28 M(+65.6%) | -$47.22 M(+18.1%) |
| Dec 2021 | -$39.99 M | -$9.83 M(-3.0%) | -$39.99 M(+11.7%) |
| Sept 2021 | - | -$10.13 M(-7.8%) | -$35.81 M(+17.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$10.98 M(+21.4%) | -$30.50 M(+32.5%) |
| Mar 2021 | - | -$9.05 M(+60.1%) | -$23.02 M(+19.8%) |
| Dec 2020 | -$19.21 M(+8.8%) | - | - |
| Dec 2020 | - | -$5.65 M(+17.1%) | -$19.21 M(+41.7%) |
| Sept 2020 | - | -$4.83 M(+38.2%) | -$13.56 M(+55.2%) |
| June 2020 | - | -$3.49 M(-33.4%) | -$8.74 M(+66.6%) |
| Mar 2020 | - | -$5.24 M | -$5.24 M |
| Dec 2019 | -$17.66 M | - | - |
FAQ
- What is Talaris Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Talaris Therapeutics?
- What is Talaris Therapeutics annual CFO year-on-year change?
- What is Talaris Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Talaris Therapeutics?
- What is Talaris Therapeutics quarterly CFO year-on-year change?
- What is Talaris Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Talaris Therapeutics?
- What is Talaris Therapeutics TTM CFO year-on-year change?
What is Talaris Therapeutics annual cash flow from operations?
The current annual CFO of TALS is -$60.86 M
What is the all time high annual CFO for Talaris Therapeutics?
Talaris Therapeutics all-time high annual cash flow from operations is -$17.66 M
What is Talaris Therapeutics annual CFO year-on-year change?
Over the past year, TALS annual cash flow from operations has changed by -$20.87 M (-52.19%)
What is Talaris Therapeutics quarterly cash flow from operations?
The current quarterly CFO of TALS is -$14.68 M
What is the all time high quarterly CFO for Talaris Therapeutics?
Talaris Therapeutics all-time high quarterly cash flow from operations is -$3.49 M
What is Talaris Therapeutics quarterly CFO year-on-year change?
Over the past year, TALS quarterly cash flow from operations has changed by +$2.60 M (+15.05%)
What is Talaris Therapeutics TTM cash flow from operations?
The current TTM CFO of TALS is -$58.88 M
What is the all time high TTM CFO for Talaris Therapeutics?
Talaris Therapeutics all-time high TTM cash flow from operations is -$5.24 M
What is Talaris Therapeutics TTM CFO year-on-year change?
Over the past year, TALS TTM cash flow from operations has changed by -$5.36 M (-10.01%)